Tag: tissue sectioning market forecast

  • Tissue Sectioning Market Growth Outlook Reveals A CAGR Of 9% And A Market Value Of $1.28 Billion By 2030

    Tissue Sectioning Market Growth Outlook Reveals A CAGR Of 9% And A Market Value Of $1.28 Billion By 2030

    Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.

    Tissue Sectioning Market Forecast Highlighting Growth From $0.9 Billion To $1.28 Billion

    The market for tissue sectioning has experienced robust expansion lately, projected to advance from $0.83 billion in 2025 to $0.91 billion in 2026, reflecting a compound annual growth rate (CAGR) of 9.9%. This historical expansion is demonstrably linked to a surge in diagnostic pathology procedures, the enhancement of hospital laboratory facilities, escalating needs for cancer diagnosis, increased biomedical research endeavors, and the broader acceptance of testing methodologies rooted in histology.

    The tissue sectioning sector is poised for significant expansion over the upcoming years, projecting a rise to $1.28 billion by 2030, driven by a compound annual growth rate (CAGR) of 9.0%. This anticipated growth during the forecast period is fueled by several key factors, including escalating investments in state-of-the-art diagnostic laboratories, a growing embrace of digital pathology processes, surging demand for diagnostics in personalized medicine, the broadening scope of academic and clinical research initiatives, and a heightened emphasis on automating laboratory operations. Prominent trends expected to shape this market in the coming years encompass the increasing implementation of automated tissue sectioning equipment, a greater need for highly precise microtomes and cryostats, the escalating utilization of disposable and standardized consumables, the wider integration of workflows within histopathology laboratories, and an intensified focus on ensuring the reproducibility and superior quality of tissue sections.

    Download A Free Sample Report For Comprehensive Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=16555&type=smp

    Tissue Sectioning Market Demand Drivers Creating New Revenue Opportunities

    An upward trend in surgical interventions is anticipated to be a significant catalyst for the expansion of the tissue sectioning market. Surgical procedures, which encompass medical operations utilizing instruments for diagnosis, treatment, or repair of bodily conditions, are experiencing an increase driven by technological progress in medicine, evolving demographic profiles, and changes in healthcare delivery models. The role of tissue sectioning is crucial in supporting these surgical endeavors by facilitating the creation of extremely thin, accurate tissue specimens essential for histological examination, thereby underpinning precise diagnoses, strategic treatment approaches, and successful transplantation outcomes. For illustration, data published in April 2025 by the Australian Institute of Health and Welfare, a governmental body in Australia, indicated that during the 2023–24 period, public hospitals admitted 778,500 patients from elective surgery waiting lists, representing a 5.8% increase from the 735,500 admissions recorded in 2022–23. Consequently, the growing volume of surgical procedures is directly contributing to the momentum of the tissue sectioning market.

    Tissue Sectioning Market Segment Landscape And Growth Potential

    The tissue sectioning market covered in this report is segmented –

    1) By Product: Accessories And Consumables, Instruments, Services

    2) By Technology: Automatic, Manual, Semi-Automatic

    3) By Application: Diagnosis, Research

    4) By End-User: Clinics, Diagnostic Laboratories, Hospitals, Research Centers

    Subsegments:

    1) By Accessories And Consumables: Microtome Blades, Staining Reagents, Tissue Embedding Media, Mounting Media, Disposable Consumables (Slides, Coverslips)

    2) By Instruments: Microtomes (Manual, Semi-Automated, Fully Automated), Cryostats, Tissue Processors, Tissue Embedding Stations, Sectioning Systems

    3) By Services: Maintenance And Repair Services, Calibration Services, Installation Services, Training Services

    Tissue Sectioning Market Trends Driving Strategic Industry Expansion

    Within the tissue sectioning sector, leading enterprises are actively innovating with sophisticated advancements, notably next-generation spatial gene expression technology, with the aim of improving tissue examination and diagnostic capabilities. This cutting-edge technology facilitates the intricate mapping of gene activity directly within tissue samples, thereby offering profound understanding of how genes are expressed in their physical context and how tissue structures are organized. As an illustration, in March of 2024, 10x Genomics, a prominent biotechnology firm based in the United States, introduced Visium HD. This particular next-generation spatial gene expression platform is engineered to render highly precise maps of gene expression across intricate anatomical regions, delivering data with single-cell level resolution from tissue sections preserved in formalin-fixed, paraffin-embedded (FFPE) formats. Consequently, this capability empowers a thorough evaluation of FFPE tissue sections by enabling the measurement of entire transcriptomes’ spatial gene expression patterns at the resolution of individual cells.

    Tissue Sectioning Market Competitive Landscape: Who Are The Leading Companies?

    Major companies operating in the tissue sectioning market are Thermo Fisher Scientific Inc., Danaher Corporation, Leica Biosystems Nussloch GmbH, Sakura Finetek USA Inc., Ted Pella Inc., Milestone Srl, Diapath S.p.A., Bio‑Optica Milano S.p.A, MEDITE Medical GmbH, PathnSitu Biotechnologies Pvt Ltd, Tanner Scientific Inc., Boeckeler Instruments Inc., SLEE Medical GmbH, Amos Scientific PTY. LTD., SM Scientific Instruments Pvt. Ltd., Bright Instrument Co. Ltd., RWD Life Science Co. Ltd., Hacker Instruments & Industries Inc., MICROM International GmbH, Epredia Inc, Histo‑Line Laboratories, PHC Holdings Co. Ltd, AGD Biomedicals Pvt Ltd, Avantik Labs

    Access The Complete Tissue Sectioning Market Report:

    https://www.thebusinessresearchcompany.com/report/tissue-sectioning-global-market-report

    Tissue Sectioning Market Global Footprint: Which Region Holds Market Leadership?

    North Americawas the largest region in the tissue sectioning market in 2025. Asia-Pacificis expected to be the fastest-growing region in the forecast period. The regions covered in the tissue sectioning market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas: +1 310-496-7795

    Asia: +44 7882 955267 & +91 8897263534

    Europe: +44 7882 955267

    Email us at: marketing@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Tissue Sectioning Market Outlook Assessing Future Opportunities And Growth Prospects

    Tissue Sectioning Market Outlook Assessing Future Opportunities And Growth Prospects

    The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

    How Much Larger Will The Tissue Sectioning Market Become By 2030 Compared To 2026?

    The tissue sectioning market size has experienced robust expansion in recent years. Projections indicate its valuation will ascend from $0.83 billion in 2025 to $0.91 billion by 2026, demonstrating a compound annual growth rate (CAGR) of 9.9%. Historically, this expansion has been driven by several factors, including an increasing volume of diagnostic pathology procedures, the expansion of hospital laboratory infrastructure, a rising demand for cancer diagnostics, growth in biomedical research activities, and a wider adoption of histology-based testing.

    The tissue sectioning market is anticipated to experience substantial expansion over the next few years. It is projected to grow to $1.28 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 9.0%. The projected increase during this period can be attributed to factors such as heightened investments in advanced diagnostic laboratories, the increasing embrace of digital pathology workflows, an escalating demand for personalized medicine diagnostics, the broadening of academic and clinical research programs, and a greater emphasis on laboratory automation. Significant trends expected in the forecast period include the rising uptake of automated tissue sectioning systems, a surging demand for high-precision microtomes and cryostats, the expanding utilization of disposable and standardized consumables, enhanced workflow integration within histopathology labs, and a sharpened focus on reproducibility and the quality of sections.

    Download A Free Sample Report For Comprehensive Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=16555&type=smp

    Which Significant Factors Are Encouraging Growth In The Tissue Sectioning Market?

    The anticipated increase in surgical procedures is projected to propel the expansion of the tissue sectioning market going forward. These procedures constitute medical interventions that utilize instruments to diagnose, treat, or repair the body. The uptick in surgical procedures is attributed to advancements in medical technology, evolving demographic patterns, and shifts in healthcare practices. Tissue sectioning plays a vital role in surgical procedures by furnishing precise, thin tissue slices for histological analysis, thereby enabling accurate diagnosis, effective treatment planning, and successful transplantation. For instance, in April 2025, according to the Australian Institute of Health and Welfare, an Australia-based government organization, reported that in 2023–24, public hospitals recorded 778,500 admissions from elective surgery waitlists, marking a 5.8% rise compared with 735,500 admissions in 2022–23. Consequently, the growing number of surgical procedures is driving the tissue sectioning market.

    What Segment Types Are Included In The Tissue Sectioning Market Analysis?

    The tissue sectioning market covered in this report is segmented –

    1) By Product: Accessories And Consumables, Instruments, Services

    2) By Technology: Automatic, Manual, Semi-Automatic

    3) By Application: Diagnosis, Research

    4) By End-User: Clinics, Diagnostic Laboratories, Hospitals, Research Centers

    Subsegments:

    1) By Accessories And Consumables: Microtome Blades, Staining Reagents, Tissue Embedding Media, Mounting Media, Disposable Consumables (Slides, Coverslips)

    2) By Instruments: Microtomes (Manual, Semi-Automated, Fully Automated), Cryostats, Tissue Processors, Tissue Embedding Stations, Sectioning Systems

    3) By Services: Maintenance And Repair Services, Calibration Services, Installation Services, Training Services

    Which Trends Are Affecting The Tissue Sectioning Market Framework?

    Major corporations are strategically forming alliances and joint ventures with emerging and mid-sized enterprises in the tissue engineering market to broaden their product and service offerings. These strategic collaborations and partnership agreements enable companies to expand their existing product portfolios and geographical reach. For instance, in June 2023, Regen Lab, a Swiss-based commercial-stage medical technology company specializing in the research, development, registration, manufacturing, and commercialization of proprietary tissue engineering products, formalized a collaboration agreement with Long Island University (LIU) and the Dassault Systèmes Group (3DS). According to the agreement’s terms, LIU and RegenLab USA will combine resources to establish an industrial innovation accelerator, which will serve as a new center of excellence dedicated to regenerative medicine and tissue engineering. Long Island University is a US-based university, and the Dassault Systèmes Group is a France-based software corporation.

    Who Are The Key Market Participants In The Tissue Sectioning Market?

    Major companies operating in the tissue sectioning market are Thermo Fisher Scientific Inc., Danaher Corporation, Leica Biosystems Nussloch GmbH, Sakura Finetek USA Inc., Ted Pella Inc., Milestone Srl, Diapath S.p.A., Bio‑Optica Milano S.p.A, MEDITE Medical GmbH, PathnSitu Biotechnologies Pvt Ltd, Tanner Scientific Inc., Boeckeler Instruments Inc., SLEE Medical GmbH, Amos Scientific PTY. LTD., SM Scientific Instruments Pvt. Ltd., Bright Instrument Co. Ltd., RWD Life Science Co. Ltd., Hacker Instruments & Industries Inc., MICROM International GmbH, Epredia Inc, Histo‑Line Laboratories, PHC Holdings Co. Ltd, AGD Biomedicals Pvt Ltd, Avantik Labs

    Access The Complete Tissue Sectioning Market Report:

    https://www.thebusinessresearchcompany.com/report/tissue-sectioning-global-market-report

    Which Region Accounts For The Highest Share Of The Tissue Sectioning Market?

    North America was the largest region in the tissue sectioning market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the tissue sectioning market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Access Tissue Sectioning Market Report for Deeper Competitive Insights

    https://www.thebusinessresearchcompany.com/customise?id=16555&type=smp

    Browse Through More Reports Similar to the Global Tissue Sectioning Market 2026, By The Business Research Company

    Facial Tissues Global Market Report 2026

    https://www.thebusinessresearchcompany.com/report/facial-tissues-global-market-report

    Tissue Diagnostic Global Market Report 2026

    https://www.thebusinessresearchcompany.com/report/tissue-diagnostic-global-market-report

    Tissue Engineering Global Market Report 2026

    https://www.thebusinessresearchcompany.com/report/tissue-engineering-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas: +1 310-496-7795

    Asia: +44 7882 955267 & +91 8897263534

    Europe: +44 7882 955267

    Email us at: marketing@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Tissue Sectioning Market Forecast with Key Trends Through 2030

    Tissue Sectioning Market Forecast with Key Trends Through 2030

    The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

    What Changes In Market Value Are Expected For The Tissue Sectioning Market Over The 2026–2030 Period?

    The tissue sectioning market has experienced robust expansion in recent years. It is forecast to grow from $0.83 billion in 2025 to $0.91 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 9.9%. The market’s historical growth can be ascribed to a surge in diagnostic pathology procedures, the enlargement of hospital laboratory infrastructure, an escalating demand for cancer diagnostics, an increase in biomedical research activities, and the broader implementation of histology-based testing.

    The tissue sectioning market is projected for substantial expansion in the coming years, with its size expected to reach $1.28 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 9.0%. This anticipated growth during the forecast period is primarily fueled by increasing investments in advanced diagnostic laboratories, the rising adoption of digital pathology workflows, a growing demand for personalized medicine diagnostics, the expansion of academic and clinical research programs, and an intensified focus on laboratory automation. Concurrently, major trends for this period include the increasing adoption of automated tissue sectioning systems, a rising demand for high-precision microtomes and cryostats, the growing use of disposable and standardized consumables, the expansion of workflow integration in histopathology labs, and an enhanced focus on reproducibility and section quality.

    Access Your Free Sample Report For In-Depth Market Analysis:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=16555&type=smp

    What Key Factors Are Affecting The Tissue Sectioning Market Demand?

    An anticipated increase in surgical operations is projected to stimulate the expansion of the tissue sectioning market in the future. These procedures constitute medical interventions that utilize instruments for the diagnosis, treatment, or restoration of the body. This surge in surgical operations can be attributed to progresses in medical technology, evolving demographics, and changes in healthcare approaches. Tissue sectioning supports surgical procedures by supplying precise, slender tissue samples for histological examination, which facilitates accurate diagnosis, meticulous treatment planning, and successful transplantation. For example, in April 2025, data from the Australian Institute of Health and Welfare, an Australian government agency, indicated that during 2023–24, public hospitals documented 778,500 admissions from elective surgery waitlists. This represents a 5.8% increase when contrasted with the 735,500 admissions recorded in 2022–23. Consequently, the growing number of surgical interventions is a key factor boosting the tissue sectioning market.

    How Is The Tissue Sectioning Market Segmented Across Different Segment Categories?

    The tissue sectioning market covered in this report is segmented –

    1) By Product: Accessories And Consumables, Instruments, Services

    2) By Technology: Automatic, Manual, Semi-Automatic

    3) By Application: Diagnosis, Research

    4) By End-User: Clinics, Diagnostic Laboratories, Hospitals, Research Centers

    Subsegments:

    1) By Accessories And Consumables: Microtome Blades, Staining Reagents, Tissue Embedding Media, Mounting Media, Disposable Consumables (Slides, Coverslips)

    2) By Instruments: Microtomes (Manual, Semi-Automated, Fully Automated), Cryostats, Tissue Processors, Tissue Embedding Stations, Sectioning Systems

    3) By Services: Maintenance And Repair Services, Calibration Services, Installation Services, Training Services

    What Trends Are Influencing Changes In The Tissue Sectioning Market?

    Major companies in the tissue sectioning market are actively developing sophisticated technologies, such as next-generation spatial gene expression technology, to improve tissue analysis and diagnostic processes. This innovative technology facilitates the precise mapping of gene activity within tissue sections, providing valuable insights into the spatial arrangement of gene expression and tissue architecture. For example, in March 2024, 10x Genomics, a US-based biotechnology company, unveiled Visium HD, which is a next-generation spatial gene expression technology. This product is engineered to enable accurate gene expression mapping within intricate anatomical structures and is designed to deliver high-resolution spatial gene expression data at single-cell scale resolution from formalin-fixed, paraffin-embedded (FFPE) tissue sections. This technology allows for the comprehensive characterization of FFPE tissue sections by measuring whole transcriptome spatial gene expression at single-cell resolution.

    Which Organizations Play A Role In The Tissue Sectioning Market Landscape?

    Major companies operating in the tissue sectioning market are Thermo Fisher Scientific Inc., Danaher Corporation, Leica Biosystems Nussloch GmbH, Sakura Finetek USA Inc., Ted Pella Inc., Milestone Srl, Diapath S.p.A., Bio-Optica Milano S.p.A, MEDITE Medical GmbH, PathnSitu Biotechnologies Pvt Ltd, Tanner Scientific Inc., Boeckeler Instruments Inc., SLEE Medical GmbH, Amos Scientific PTY. LTD., SM Scientific Instruments Pvt. Ltd., Bright Instrument Co. Ltd., RWD Life Science Co. Ltd., Hacker Instruments & Industries Inc., MICROM International GmbH, Epredia Inc, Histo-Line Laboratories, PHC Holdings Co. Ltd, AGD Biomedicals Pvt Ltd, Avantik Labs

    Get The Full Tissue Sectioning Market Report:

    https://www.thebusinessresearchcompany.com/report/tissue-sectioning-global-market-report

    Which Geographic Region Dominates The Tissue Sectioning Market?

    North America was the largest region in the tissue sectioning market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the tissue sectioning market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request A Customized Tissue Sectioning Market Report For Competitive Insights:

    https://www.thebusinessresearchcompany.com/report/tissue-sectioning-global-market-report

    Browse Through More Reports Similar to the Global Tissue Sectioning Market 2026, By The Business Research Company

    Facial Tissues Market Report 2026

    https://www.thebusinessresearchcompany.com/report/facial-tissues-global-market-report

    Tissue Diagnostic Market Report

    https://www.thebusinessresearchcompany.com/report/tissue-diagnostic-global-market-report

    Tissue Engineering Market Report

    https://www.thebusinessresearchcompany.com/report/tissue-engineering-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • An Important Factor Driving the Tissue Sectioning Market Is the Rising Surgical Procedures Propelling Tissue Sectioning Market Growth

    An Important Factor Driving the Tissue Sectioning Market Is the Rising Surgical Procedures Propelling Tissue Sectioning Market Growth

    The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

    What Is The Market Size Of The Tissue Sectioning Market In 2026 And What Value Is Projected For 2030?

    The tissue sectioning market has experienced substantial expansion in recent years. It is projected to climb from $0.83 billion in 2025 to $0.91 billion in 2026, achieving a compound annual growth rate (CAGR) of 9.9%. Historically, this market’s development can be attributed to an increasing volume of diagnostic pathology procedures, the expansion of hospital laboratory infrastructure, a rising demand for cancer diagnostics, growth in biomedical research activities, and a wider adoption of histology-based testing.

    The tissue sectioning market is projected to experience substantial growth over the coming years, reaching a valuation of $1.28 billion by 2030, with a compound annual growth rate (CAGR) of 9.0%. This anticipated expansion during the forecast period is fueled by several factors, including increased investments in advanced diagnostic laboratories, the rising adoption of digital pathology workflows, a growing demand for personalized medicine diagnostics, the expansion of academic and clinical research programs, and a heightened focus on laboratory automation. Key trends expected in this period encompass the increasing integration of automated tissue sectioning systems, a rising need for high-precision microtomes and cryostats, the growing utilization of disposable and standardized consumables, the broadening of workflow integration within histopathology laboratories, and an enhanced emphasis on reproducibility and the quality of sections.

    Download the Free Sample Report to Explore Key Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=16555&type=smp

    What Key Drivers Are Influencing The Growth Of The Tissue Sectioning Market?

    The increase in surgical interventions is projected to fuel the expansion of the tissue sectioning market moving forward. Surgical procedures are defined as medical operations that employ instruments to identify, address, or mend parts of the body. The uptick in these procedures stems from improvements in medical technology, demographic shifts, and evolving healthcare approaches. Tissue sectioning supports surgical procedures by supplying precise, thin slices of tissue for histological examination, which facilitates accurate diagnosis, treatment planning, and transplantation. For instance, in April 2025, the Australian Institute of Health and Welfare, a government organization based in Australia, stated that public hospitals recorded 778,500 admissions from elective surgery waitlists in 2023–24, marking a 5.8% increase compared with 735,500 admissions in 2022–23. Consequently, the growing number of surgical procedures is propelling the tissue sectioning market.

    What Are The Key Segments Of The Tissue Sectioning Market?

    The tissue sectioning market covered in this report is segmented –

    1) By Product: Accessories And Consumables, Instruments, Services

    2) By Technology: Automatic, Manual, Semi-Automatic

    3) By Application: Diagnosis, Research

    4) By End-User: Clinics, Diagnostic Laboratories, Hospitals, Research Centers

    Subsegments:

    1) By Accessories And Consumables: Microtome Blades, Staining Reagents, Tissue Embedding Media, Mounting Media, Disposable Consumables (Slides, Coverslips)

    2) By Instruments: Microtomes (Manual, Semi-Automated, Fully Automated), Cryostats, Tissue Processors, Tissue Embedding Stations, Sectioning Systems

    3) By Services: Maintenance And Repair Services, Calibration Services, Installation Services, Training Services

    Which Trends Are Influencing The Tissue Sectioning Market?

    Leading firms within the tissue sectioning market are innovating advanced solutions, specifically next-generation spatial gene expression technology, aimed at improving tissue analysis and diagnostic capabilities. This advanced spatial gene expression technology facilitates a comprehensive mapping of gene activity within tissue samples, thereby offering clarity on the spatial arrangement of gene expression and the overall tissue architecture. An example is 10x Genomics, a US-based biotechnology firm, which introduced Visium HD in March 2024. This particular next-generation spatial gene expression technology is designed to enable accurate gene expression mapping within intricate anatomical structures. Its purpose is to deliver high-resolution spatial gene expression data, even at single-cell scale, when working with formalin-fixed, paraffin-embedded (FFPE) tissue sections. Consequently, this innovation permits a thorough characterization of FFPE tissue sections through the measurement of whole transcriptome spatial gene expression with single-cell precision.

    Who Are The Leading Companies Operating In The Tissue Sectioning Market?

    Major companies operating in the tissue sectioning market are Thermo Fisher Scientific Inc., Danaher Corporation, Leica Biosystems Nussloch GmbH, Sakura Finetek USA Inc., Ted Pella Inc., Milestone Srl, Diapath S.p.A., Bio-Optica Milano S.p.A, MEDITE Medical GmbH, PathnSitu Biotechnologies Pvt Ltd, Tanner Scientific Inc., Boeckeler Instruments Inc., SLEE Medical GmbH, Amos Scientific PTY. LTD., SM Scientific Instruments Pvt. Ltd., Bright Instrument Co. Ltd., RWD Life Science Co. Ltd., Hacker Instruments & Industries Inc., MICROM International GmbH, Epredia Inc, Histo-Line Laboratories, PHC Holdings Co. Ltd, AGD Biomedicals Pvt Ltd, Avantik Labs

    Read the full tissue sectioning market report here:

    https://www.thebusinessresearchcompany.com/report/tissue-sectioning-global-market-report

    Which Region Is Expected To Register The Fastest Growth In The Tissue Sectioning Market?

    North America was the largest region in the tissue sectioning market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the tissue sectioning market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request A Tailored Tissue Sectioning Market Research Report For Competitive Advantage:

    https://www.thebusinessresearchcompany.com/customise?id=16555&type=smp

    Browse Through More Reports Similar to the Global Tissue Sectioning Market 2026, By The Business Research Company

    Facial Tissues Global Market Report

    https://www.thebusinessresearchcompany.com/report/facial-tissues-global-market-report

    Tissue Diagnostic Global Market Report

    https://www.thebusinessresearchcompany.com/report/tissue-diagnostic-global-market-report

    Tissue Engineering Global Market Report

    https://www.thebusinessresearchcompany.com/report/tissue-engineering-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • An Important Factor Driving the Tissue Sectioning Market Is the Rising Surgical Procedures Propelling Tissue Sectioning Market Growth

    An Important Factor Driving the Tissue Sectioning Market Is the Rising Surgical Procedures Propelling Tissue Sectioning Market Growth

    The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

    What Is The Market Size Of The Tissue Sectioning Market In 2026 And What Value Is Projected For 2030?

    The tissue sectioning market has experienced substantial expansion in recent years. It is projected to climb from $0.83 billion in 2025 to $0.91 billion in 2026, achieving a compound annual growth rate (CAGR) of 9.9%. Historically, this market’s development can be attributed to an increasing volume of diagnostic pathology procedures, the expansion of hospital laboratory infrastructure, a rising demand for cancer diagnostics, growth in biomedical research activities, and a wider adoption of histology-based testing.

    The tissue sectioning market is projected to experience substantial growth over the coming years, reaching a valuation of $1.28 billion by 2030, with a compound annual growth rate (CAGR) of 9.0%. This anticipated expansion during the forecast period is fueled by several factors, including increased investments in advanced diagnostic laboratories, the rising adoption of digital pathology workflows, a growing demand for personalized medicine diagnostics, the expansion of academic and clinical research programs, and a heightened focus on laboratory automation. Key trends expected in this period encompass the increasing integration of automated tissue sectioning systems, a rising need for high-precision microtomes and cryostats, the growing utilization of disposable and standardized consumables, the broadening of workflow integration within histopathology laboratories, and an enhanced emphasis on reproducibility and the quality of sections.

    Download the Free Sample Report to Explore Key Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=16555&type=smp

    What Key Drivers Are Influencing The Growth Of The Tissue Sectioning Market?

    The increase in surgical interventions is projected to fuel the expansion of the tissue sectioning market moving forward. Surgical procedures are defined as medical operations that employ instruments to identify, address, or mend parts of the body. The uptick in these procedures stems from improvements in medical technology, demographic shifts, and evolving healthcare approaches. Tissue sectioning supports surgical procedures by supplying precise, thin slices of tissue for histological examination, which facilitates accurate diagnosis, treatment planning, and transplantation. For instance, in April 2025, the Australian Institute of Health and Welfare, a government organization based in Australia, stated that public hospitals recorded 778,500 admissions from elective surgery waitlists in 2023–24, marking a 5.8% increase compared with 735,500 admissions in 2022–23. Consequently, the growing number of surgical procedures is propelling the tissue sectioning market.

    What Are The Key Segments Of The Tissue Sectioning Market?

    The tissue sectioning market covered in this report is segmented –

    1) By Product: Accessories And Consumables, Instruments, Services

    2) By Technology: Automatic, Manual, Semi-Automatic

    3) By Application: Diagnosis, Research

    4) By End-User: Clinics, Diagnostic Laboratories, Hospitals, Research Centers

    Subsegments:

    1) By Accessories And Consumables: Microtome Blades, Staining Reagents, Tissue Embedding Media, Mounting Media, Disposable Consumables (Slides, Coverslips)

    2) By Instruments: Microtomes (Manual, Semi-Automated, Fully Automated), Cryostats, Tissue Processors, Tissue Embedding Stations, Sectioning Systems

    3) By Services: Maintenance And Repair Services, Calibration Services, Installation Services, Training Services

    Which Trends Are Influencing The Tissue Sectioning Market?

    Leading firms within the tissue sectioning market are innovating advanced solutions, specifically next-generation spatial gene expression technology, aimed at improving tissue analysis and diagnostic capabilities. This advanced spatial gene expression technology facilitates a comprehensive mapping of gene activity within tissue samples, thereby offering clarity on the spatial arrangement of gene expression and the overall tissue architecture. An example is 10x Genomics, a US-based biotechnology firm, which introduced Visium HD in March 2024. This particular next-generation spatial gene expression technology is designed to enable accurate gene expression mapping within intricate anatomical structures. Its purpose is to deliver high-resolution spatial gene expression data, even at single-cell scale, when working with formalin-fixed, paraffin-embedded (FFPE) tissue sections. Consequently, this innovation permits a thorough characterization of FFPE tissue sections through the measurement of whole transcriptome spatial gene expression with single-cell precision.

    Who Are The Leading Companies Operating In The Tissue Sectioning Market?

    Major companies operating in the tissue sectioning market are Thermo Fisher Scientific Inc., Danaher Corporation, Leica Biosystems Nussloch GmbH, Sakura Finetek USA Inc., Ted Pella Inc., Milestone Srl, Diapath S.p.A., Bio-Optica Milano S.p.A, MEDITE Medical GmbH, PathnSitu Biotechnologies Pvt Ltd, Tanner Scientific Inc., Boeckeler Instruments Inc., SLEE Medical GmbH, Amos Scientific PTY. LTD., SM Scientific Instruments Pvt. Ltd., Bright Instrument Co. Ltd., RWD Life Science Co. Ltd., Hacker Instruments & Industries Inc., MICROM International GmbH, Epredia Inc, Histo-Line Laboratories, PHC Holdings Co. Ltd, AGD Biomedicals Pvt Ltd, Avantik Labs

    Read the full tissue sectioning market report here:

    https://www.thebusinessresearchcompany.com/report/tissue-sectioning-global-market-report

    Which Region Is Expected To Register The Fastest Growth In The Tissue Sectioning Market?

    North America was the largest region in the tissue sectioning market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the tissue sectioning market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request A Tailored Tissue Sectioning Market Research Report For Competitive Advantage:

    https://www.thebusinessresearchcompany.com/customise?id=16555&type=smp

    Browse Through More Reports Similar to the Global Tissue Sectioning Market 2026, By The Business Research Company

    Facial Tissues Global Market Report

    https://www.thebusinessresearchcompany.com/report/facial-tissues-global-market-report

    Tissue Diagnostic Global Market Report

    https://www.thebusinessresearchcompany.com/report/tissue-diagnostic-global-market-report

    Tissue Engineering Global Market Report

    https://www.thebusinessresearchcompany.com/report/tissue-engineering-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • An Important Factor Driving the Tissue Sectioning Market Is the Rising Surgical Procedures Propelling Tissue Sectioning Market Growth

    An Important Factor Driving the Tissue Sectioning Market Is the Rising Surgical Procedures Propelling Tissue Sectioning Market Growth

    The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

    What Is The Market Size Of The Tissue Sectioning Market In 2026 And What Value Is Projected For 2030?

    The tissue sectioning market has experienced substantial expansion in recent years. It is projected to climb from $0.83 billion in 2025 to $0.91 billion in 2026, achieving a compound annual growth rate (CAGR) of 9.9%. Historically, this market’s development can be attributed to an increasing volume of diagnostic pathology procedures, the expansion of hospital laboratory infrastructure, a rising demand for cancer diagnostics, growth in biomedical research activities, and a wider adoption of histology-based testing.

    The tissue sectioning market is projected to experience substantial growth over the coming years, reaching a valuation of $1.28 billion by 2030, with a compound annual growth rate (CAGR) of 9.0%. This anticipated expansion during the forecast period is fueled by several factors, including increased investments in advanced diagnostic laboratories, the rising adoption of digital pathology workflows, a growing demand for personalized medicine diagnostics, the expansion of academic and clinical research programs, and a heightened focus on laboratory automation. Key trends expected in this period encompass the increasing integration of automated tissue sectioning systems, a rising need for high-precision microtomes and cryostats, the growing utilization of disposable and standardized consumables, the broadening of workflow integration within histopathology laboratories, and an enhanced emphasis on reproducibility and the quality of sections.

    Download the Free Sample Report to Explore Key Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=16555&type=smp

    What Key Drivers Are Influencing The Growth Of The Tissue Sectioning Market?

    The increase in surgical interventions is projected to fuel the expansion of the tissue sectioning market moving forward. Surgical procedures are defined as medical operations that employ instruments to identify, address, or mend parts of the body. The uptick in these procedures stems from improvements in medical technology, demographic shifts, and evolving healthcare approaches. Tissue sectioning supports surgical procedures by supplying precise, thin slices of tissue for histological examination, which facilitates accurate diagnosis, treatment planning, and transplantation. For instance, in April 2025, the Australian Institute of Health and Welfare, a government organization based in Australia, stated that public hospitals recorded 778,500 admissions from elective surgery waitlists in 2023–24, marking a 5.8% increase compared with 735,500 admissions in 2022–23. Consequently, the growing number of surgical procedures is propelling the tissue sectioning market.

    What Are The Key Segments Of The Tissue Sectioning Market?

    The tissue sectioning market covered in this report is segmented –

    1) By Product: Accessories And Consumables, Instruments, Services

    2) By Technology: Automatic, Manual, Semi-Automatic

    3) By Application: Diagnosis, Research

    4) By End-User: Clinics, Diagnostic Laboratories, Hospitals, Research Centers

    Subsegments:

    1) By Accessories And Consumables: Microtome Blades, Staining Reagents, Tissue Embedding Media, Mounting Media, Disposable Consumables (Slides, Coverslips)

    2) By Instruments: Microtomes (Manual, Semi-Automated, Fully Automated), Cryostats, Tissue Processors, Tissue Embedding Stations, Sectioning Systems

    3) By Services: Maintenance And Repair Services, Calibration Services, Installation Services, Training Services

    Which Trends Are Influencing The Tissue Sectioning Market?

    Leading firms within the tissue sectioning market are innovating advanced solutions, specifically next-generation spatial gene expression technology, aimed at improving tissue analysis and diagnostic capabilities. This advanced spatial gene expression technology facilitates a comprehensive mapping of gene activity within tissue samples, thereby offering clarity on the spatial arrangement of gene expression and the overall tissue architecture. An example is 10x Genomics, a US-based biotechnology firm, which introduced Visium HD in March 2024. This particular next-generation spatial gene expression technology is designed to enable accurate gene expression mapping within intricate anatomical structures. Its purpose is to deliver high-resolution spatial gene expression data, even at single-cell scale, when working with formalin-fixed, paraffin-embedded (FFPE) tissue sections. Consequently, this innovation permits a thorough characterization of FFPE tissue sections through the measurement of whole transcriptome spatial gene expression with single-cell precision.

    Who Are The Leading Companies Operating In The Tissue Sectioning Market?

    Major companies operating in the tissue sectioning market are Thermo Fisher Scientific Inc., Danaher Corporation, Leica Biosystems Nussloch GmbH, Sakura Finetek USA Inc., Ted Pella Inc., Milestone Srl, Diapath S.p.A., Bio-Optica Milano S.p.A, MEDITE Medical GmbH, PathnSitu Biotechnologies Pvt Ltd, Tanner Scientific Inc., Boeckeler Instruments Inc., SLEE Medical GmbH, Amos Scientific PTY. LTD., SM Scientific Instruments Pvt. Ltd., Bright Instrument Co. Ltd., RWD Life Science Co. Ltd., Hacker Instruments & Industries Inc., MICROM International GmbH, Epredia Inc, Histo-Line Laboratories, PHC Holdings Co. Ltd, AGD Biomedicals Pvt Ltd, Avantik Labs

    Read the full tissue sectioning market report here:

    https://www.thebusinessresearchcompany.com/report/tissue-sectioning-global-market-report

    Which Region Is Expected To Register The Fastest Growth In The Tissue Sectioning Market?

    North America was the largest region in the tissue sectioning market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the tissue sectioning market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request A Tailored Tissue Sectioning Market Research Report For Competitive Advantage:

    https://www.thebusinessresearchcompany.com/customise?id=16555&type=smp

    Browse Through More Reports Similar to the Global Tissue Sectioning Market 2026, By The Business Research Company

    Facial Tissues Global Market Report

    https://www.thebusinessresearchcompany.com/report/facial-tissues-global-market-report

    Tissue Diagnostic Global Market Report

    https://www.thebusinessresearchcompany.com/report/tissue-diagnostic-global-market-report

    Tissue Engineering Global Market Report

    https://www.thebusinessresearchcompany.com/report/tissue-engineering-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Tissue Sectioning Market Outlook 2026–2030: Key Business Drivers and Trends

    Tissue Sectioning Market Outlook 2026–2030: Key Business Drivers and Trends

    Uncover key drivers, emerging technologies, and competitive movements shaping the tissue sectioning market from 2026–2035 with trusted insights from The Business Research Company

    By how much is the Tissue Sectioning Market expected to grow between 2026 and 2030?

    The tissue sectioning market size has demonstrated robust growth in recent years. It is anticipated to expand from $0.83 billion in 2025 to $0.91 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 9.9%. Historically, this expansion has been driven by the increasing volume of diagnostic pathology procedures, the development of hospital laboratory infrastructure, a growing demand for cancer diagnostics, the rise in biomedical research activities, and the wider acceptance of histology-based testing.

    The tissue sectioning market size is anticipated to experience substantial growth in the upcoming years, with projections indicating it will reach $1.28 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 9.0%. This expansion during the forecast period is primarily driven by heightened investments in advanced diagnostic laboratories, the increasing embrace of digital pathology workflows, a growing demand for personalized medicine diagnostics, the broadening of academic and clinical research programs, and a greater emphasis on laboratory automation. Noteworthy trends expected over this period include the wider adoption of automated tissue sectioning systems, a rising demand for high-precision microtomes and cryostats, the expanding use of disposable and standardized consumables, enhanced workflow integration within histopathology laboratories, and an increased focus on reproducibility and section quality.

    Access Your Free Sample Report for In-Depth Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=16555&type=smp

    Which Drivers Are Influencing Market Acceleration In The Tissue Sectioning Market?

    The anticipated increase in surgical procedures is projected to drive the expansion of the tissue sectioning market in the future. Surgical procedures are medical interventions that use instruments to diagnose, treat, or repair the body. The rise in these procedures is attributed to advancements in medical technology, demographic shifts, and changes in healthcare practices. Tissue sectioning supports surgical procedures by providing precise, thin tissue slices for histological analysis, which enables accurate diagnosis, treatment planning, and transplantation. For example, in April 2025, the Australian Institute of Health and Welfare, an Australia-based government organization, reported that in 2023–24, public hospitals recorded 778,500 admissions from elective surgery waitlists, marking a 5.8% rise compared with 735,500 admissions in 2022–23. Consequently, the growing number of surgical procedures is propelling the tissue sectioning market.

    What Leading Segments Are Studied In The Tissue Sectioning Market?

    The tissue sectioning market covered in this report is segmented –

    1) By Product: Accessories And Consumables, Instruments, Services

    2) By Technology: Automatic, Manual, Semi-Automatic

    3) By Application: Diagnosis, Research

    4) By End-User: Clinics, Diagnostic Laboratories, Hospitals, Research Centers

    Subsegments:

    1) By Accessories And Consumables: Microtome Blades, Staining Reagents, Tissue Embedding Media, Mounting Media, Disposable Consumables (Slides, Coverslips)

    2) By Instruments: Microtomes (Manual, Semi-Automated, Fully Automated), Cryostats, Tissue Processors, Tissue Embedding Stations, Sectioning Systems

    3) By Services: Maintenance And Repair Services, Calibration Services, Installation Services, Training Services

    Which Trends Are Expected To Influence The Tissue Sectioning Market In The Upcoming Years?

    Leading companies within the tissue sectioning market are developing advanced technologies, including next-generation spatial gene expression technology, to improve tissue analysis and diagnostics. This sophisticated spatial gene expression technology enables the precise mapping of gene activity within tissue sections, thereby offering insights into the spatial organization of gene expression and the structural makeup of tissues. As an illustration, in March 2024, 10x Genomics, a US-based biotechnology company, unveiled Visium HD, a next-generation spatial gene expression technology designed for accurate gene expression mapping within detailed anatomical structures. It is engineered to deliver high-resolution spatial gene expression data at a single-cell scale resolution from formalin-fixed, paraffin-embedded (FFPE) tissue sections. This technology allows for a comprehensive characterization of FFPE tissue sections through the measurement of whole transcriptome spatial gene expression at single-cell resolution.

    Which Major Industry Participants Are Leading The Tissue Sectioning Market Growth?

    Major companies operating in the tissue sectioning market are Thermo Fisher Scientific Inc., Danaher Corporation, Leica Biosystems Nussloch GmbH, Sakura Finetek USA Inc., Ted Pella Inc., Milestone Srl, Diapath S.p.A., Bio-Optica Milano S.p.A, MEDITE Medical GmbH, PathnSitu Biotechnologies Pvt Ltd, Tanner Scientific Inc., Boeckeler Instruments Inc., SLEE Medical GmbH, Amos Scientific PTY. LTD., SM Scientific Instruments Pvt. Ltd., Bright Instrument Co. Ltd., RWD Life Science Co. Ltd., Hacker Instruments & Industries Inc., MICROM International GmbH, Epredia Inc, Histo-Line Laboratories, PHC Holdings Co. Ltd, AGD Biomedicals Pvt Ltd, Avantik Labs

    Access The Complete Report For Deeper Market Insights:

    https://www.thebusinessresearchcompany.com/report/tissue-sectioning-global-market-report

    Which Region Is Projected To Lead The Tissue Sectioning Market During The Forecast Period?

    North America was the largest region in the tissue sectioning market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the tissue sectioning market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request Your Customized Tissue Sectioning Market Research Report for Competitive Advantage:

    https://www.thebusinessresearchcompany.com/customise?id=16555&type=smp

    Browse Through More Reports Similar to the Global Tissue Sectioning Market 2026, By The Business Research Company

    Tissue Engineering Market Report 2026

    https://www.thebusinessresearchcompany.com/report/tissue-engineering-global-market-report

    Facial Tissues Market Report 2026

    https://www.thebusinessresearchcompany.com/report/facial-tissues-global-market-report

    Tissue Diagnostic Market Report 2026

    https://www.thebusinessresearchcompany.com/report/tissue-diagnostic-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Which Emerging Trends Are Driving The Tissue Sectioning Market Toward $1.19 Billion By 2029?

    Which Emerging Trends Are Driving The Tissue Sectioning Market Toward $1.19 Billion By 2029?

    Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

    How Is The Tissue Sectioning Market Expected To Grow In Terms Of Size?

    The market size of tissue sectioning has seen robust growth in the recent past. It is projected to escalate from $0.76 billion in 2024 to $0.83 billion in 2025, representing a compound annual growth rate (CAGR) of 9.2%. The driving factors behind the historic growth include an increase in chronic diseases, an expanding aging population, higher investment in life sciences research, growth in biotech and pharmaceutical sectors, government support for research, rising demand for companion diagnostics, increased awareness about early disease detection, and growth in the field of regenerative medicine.

    It is anticipated that the market for tissue sectioning will experience robust growth in the ensuing years, with its worth estimated to reach $1.19 billion by 2029, showing a compound annual growth rate (CAGR) of 9.5%. Factors contributing to this growth during the predicted period include the rising demand for personalized treatment, expansion of biobanks, increasing investment in research and development, escalated healthcare spending, heightened awareness for early disease identification, the arrival of digital pathology, increased need for biomarker discovery, and a flourishing biopharmaceutical sector, with a heightened need for point of care testing. Key trends anticipated during this future period involve advancements in automated technology, the amalgamation of AI and machine learning, incorporation of digital pathology, the use of 3D tissue sectioning methods, the invention of high throughput solutions, broadened research applications, the creation of innovative cutting techniques, improvements in imaging modes, and the adoption of cryosectioning techniques.

    Get A Free Sample Of The Report:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=16555&type=smp

    Which Key Factors Are Fueling Growth In The Tissue Sectioning Market?

    The growth of the tissue sectioning market is being propelled by the increasing number of surgical procedures. Surgical interventions, which involve the use of instruments to diagnose, treat, or mend the body, are on the rise due to advancements in medical technology, demographic changes, and modifications in healthcare practices. Tissue sectioning enhances surgical procedures by delivering precise, thin tissue slices for histological analysis, which facilitates accurate diagnosis, treatment planning, and transplantation. For instance, data from the Australian Institute of Health and Welfare (AIHW), a government agency in Australia that focuses on public health and welfare, indicated that in the period between 2022-2023, 735,500 patients were admitted for surgery from public hospital elective surgery waiting lists, showing an 18% increase from 2021-2022. As a result, the increase in surgical procedures is fuelling the expansion of the tissue sectioning market.

    How Is The Tissue Sectioning Market Categorized Across Applications And Types?

    The tissue sectioningmarket covered in this report is segmented –

    1) By Product: Accessories And Consumables; Instruments; Services

    2) By Technology: Automatic; Manual; Semi-Automatic

    3) By Application: Diagnosis; Research

    4) By End-User: Clinics; Diagnostic Laboratories; Hospitals; Research Centers

    Subsegments:

    1) By Accessories And Consumables: Microtome Blades; Staining Reagents; Tissue Embedding Media; Mounting Media; Disposable Consumables (Slides, Coverslips)

    2) By Instruments: Microtomes (Manual, Semi-Automated, Fully Automated); Cryostats; Tissue Processors; Tissue Embedding Stations; Sectioning Systems

    3) By Services: Maintenance And Repair Services; Calibration Services; Installation Services; Training Services

    Which Emerging Trends Are Reshaping The Tissue Sectioning Market Landscape?

    Critical players in the tissue sectioning market are pioneering advanced techniques like next-generation spatial gene expression technology to improve tissue analysis and diagnostics. This innovative technology facilitates comprehensive mapping of gene activity inside tissue sections, offering valuable insights into the spatial layout of gene expression and tissue architecture. For example, in March 2024, 10x Genomics, a biotechnology firm based in the US, unveiled Visium HD, a cutting-edge spatial gene expression technology that enables accurate gene expression mapping in intricate anatomical structures. This technology is built to deliver high-resolution spatial gene expression data at a single-cell scale resolution from formalin-fixed, paraffin-embedded (FFPE) tissue sections. It enables detailed characterization of FFPE tissue sections by gauging whole transcriptome spatial gene expression at single-cell resolution.

    Which Firms Are Making The Biggest Impact In The Tissue Sectioning Market?

    Major companies operating in the tissue sectioning market are Thermo Fisher Scientific Inc., Danaher Corporation, Labcorp Drug Development, Agilent Technologies Inc., Leica Biosystems Nussloch GmbH, Abcam Limited, Sakura Finetek USA Inc., Ted Pella Inc., Santa Cruz Biotechnology Inc., Milestone Srl, Diapath S.p.A., Bio-Optica Milano S.p.A, MEDITE Medical GmbH, PathnSitu Biotechnologies Pvt Ltd, Tanner Scientific Inc., Boeckeler Instruments Inc., SLEE Medical GmbH, Amos Scientific PTY. LTD., LLS ROWIAK LaserLabSolutions GmbH, SM Scientific Instruments Pvt. Ltd., Bright Instrument Co. Ltd., RWD Life Science Co. Ltd., Hacker Instruments & Industries Inc.

    Access The Complete Report Here:

    https://www.thebusinessresearchcompany.com/report/tissue-sectioning-global-market-report

    Which Region Holds The Greatest Opportunity For Tissue Sectioning Market Expansion?

    North America was the largest region in the tissue sectioning market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the tissue sectioning market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Customize Your Report Here:

    https://www.thebusinessresearchcompany.com/customise?id=16555&type=smp

    Browse Through More Reports Similar to the Global Tissue Sectioning Market 2025, By The Business Research Company

    Soft Tissue Repair Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/soft-tissue-repair-global-market-report

    Tissue Diagnostic Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/tissue-diagnostic-global-market-report

    Cardiovascular And Soft Tissue Repair Patches Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/cardiovascular-and-soft-tissue-repair-patches-global-market-report

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Tissue Sectioning Market Forecast: What to Expect by 2029

    Tissue Sectioning Market Forecast: What to Expect by 2029

    Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

    What Are The Forecasted Market Size Estimates For The Tissue Sectioning Market Between 2025 And 2029?

    The tissue sectioning market has seen significant expansion in recent years. It is forecast to increase from $0.76 billion in 2024 to $0.83 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 9.2%. Historically, this growth has been driven by factors such as the increasing prevalence of chronic diseases, an expanding aging population, rising investments in life sciences research, the growth of the biotechnology and pharmaceutical industries, government initiatives supporting research, a rising demand for companion diagnostics, increasing awareness about early disease detection, and developments in regenerative medicine.

    The tissue sectioning market is projected to experience robust expansion over the coming years, reaching a valuation of $1.19 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 9.5%. This anticipated growth during the forecast period is driven by several factors, including the increasing demand for personalized medicine, the expansion of biobanks, substantial investments in research and development, rising healthcare expenditure, enhanced awareness regarding early disease detection, the emergence of digital pathology, a growing need for biomarker discovery, the expanding biopharmaceutical industry, and the rising demand for point-of-care testing. Key trends shaping the market in this period encompass advancements in automation technology, the integration of artificial intelligence and machine learning, the broader adoption of digital pathology, the application of 3D tissue sectioning techniques, the creation of high-throughput solutions, an increase in research applications, the development of innovative cutting techniques, improvements in imaging modalities, and the wider use of cryosectioning techniques.

    Unlock Your Free Sample Report for Exclusive Market Data:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=16555&type=smp

    What Are The Main Drivers Boosting The Tissue Sectioning Industry’s Expansion?

    The anticipated increase in surgical operations is projected to drive the expansion of the tissue sectioning market moving ahead. These procedures involve medical interventions that utilize instruments for diagnosing, treating, or repairing parts of the body. The growth in surgical procedures can be attributed to progress in medical technology, demographic shifts, and evolving healthcare practices. Tissue sectioning supports surgical procedures by supplying precise, slender tissue samples for histological examination, which facilitates accurate diagnosis, treatment formulation, and transplantation. As an illustration, data from December 2023, provided by the Australian Institute of Health and Welfare (AIHW), an Australian government agency focused on public health and welfare, indicated that in 2022–23, 735,500 patients were admitted for operations from public hospital elective surgery waiting lists. This figure marked an 18% increase compared to 2021–22. Consequently, the increasing number of surgical interventions is fueling the tissue sectioning market.

    How Is The Tissue Sectioning Market Classified Into Different Segments?

    The tissue sectioningmarket covered in this report is segmented –

    1) By Product: Accessories And Consumables; Instruments; Services

    2) By Technology: Automatic; Manual; Semi-Automatic

    3) By Application: Diagnosis; Research

    4) By End-User: Clinics; Diagnostic Laboratories; Hospitals; Research Centers

    Subsegments:

    1) By Accessories And Consumables: Microtome Blades; Staining Reagents; Tissue Embedding Media; Mounting Media; Disposable Consumables (Slides, Coverslips)

    2) By Instruments: Microtomes (Manual, Semi-Automated, Fully Automated); Cryostats; Tissue Processors; Tissue Embedding Stations; Sectioning Systems

    3) By Services: Maintenance And Repair Services; Calibration Services; Installation Services; Training Services

    How Are Emerging Market Trends Shaping The Tissue Sectioning Industry Landscape?

    Major companies operating in the tissue sectioning market are advancing technologies, such as next-generation spatial gene expression technology, to improve tissue analysis and diagnostics. This next-generation spatial gene expression technology enables detailed mapping of gene activity within tissue sections, providing insights into the spatial organization of gene expression and tissue architecture. As an illustration, in March 2024, 10x Genomics, a US-based biotechnology company, launched Visium HD. This next-generation spatial gene expression technology allows for precise gene expression mapping in detailed anatomical structures and is designed to deliver high-resolution spatial gene expression data at single-cell scale resolution from formalin-fixed, paraffin-embedded (FFPE) tissue sections. It facilitates comprehensive characterization of FFPE tissue sections by measuring whole transcriptome spatial gene expression at single-cell resolution.

    Which Industry Leaders Are Driving Innovation Across The Tissue Sectioning Market?

    Major companies operating in the tissue sectioning market are Thermo Fisher Scientific Inc., Danaher Corporation, Labcorp Drug Development, Agilent Technologies Inc., Leica Biosystems Nussloch GmbH, Abcam Limited, Sakura Finetek USA Inc., Ted Pella Inc., Santa Cruz Biotechnology Inc., Milestone Srl, Diapath S.p.A., Bio-Optica Milano S.p.A, MEDITE Medical GmbH, PathnSitu Biotechnologies Pvt Ltd, Tanner Scientific Inc., Boeckeler Instruments Inc., SLEE Medical GmbH, Amos Scientific PTY. LTD., LLS ROWIAK LaserLabSolutions GmbH, SM Scientific Instruments Pvt. Ltd., Bright Instrument Co. Ltd., RWD Life Science Co. Ltd., Hacker Instruments & Industries Inc.

    Download The Full Report For Exclusive Market Findings:

    https://www.thebusinessresearchcompany.com/report/tissue-sectioning-global-market-report

    Which Regional Markets Are Contributing Most To The Tissue Sectioning Industry Expansion?

    North America was the largest region in the tissue sectioning market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the tissue sectioning market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request A Customized Version Of The Tissue Sectioning Market Report:

    https://www.thebusinessresearchcompany.com/customise?id=16555&type=smp

    Browse Through More Reports Similar to the Global Tissue Sectioning Market 2025, By The Business Research Company

    Soft Tissue Repair Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/soft-tissue-repair-global-market-report

    Tissue Diagnostic Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/tissue-diagnostic-global-market-report

    Cardiovascular And Soft Tissue Repair Patches Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/cardiovascular-and-soft-tissue-repair-patches-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Tissue Sectioning Market Insights: In-Depth Look at Growth Trends, Market Size, and Opportunities for 2025-2034

    Tissue Sectioning Market Insights: In-Depth Look at Growth Trends, Market Size, and Opportunities for 2025-2034

    Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

    How Has the Tissue Sectioning Market Growth Performance Trended Historically, And What Lies Ahead?

    There has been a robust growth in the tissue sectioning market size in the last few years. Its growth projection shows an increase from $0.76 billion in 2024 to $0.83 billion in 2025, with a compound annual growth rate (CAGR) of 9.2%. The growth witnessed during the historic period is largely due to the rising incidence of chronic diseases, an increasing aging population, heightened investments in life sciences research, expansion of the biotechnology and pharmaceutical sectors, governmental support for research, increased demand for companion diagnostics, improved awareness regarding early detection of diseases, and advancement in regenerative medicine.

    The market for tissue sectioning is anticipated to witness impressive growth in the ensuing few years. Projected to reach$1.19 billion in 2029 with a compound annual growth rate (CAGR) of 9.5%, the growth during the anticipated period can be credited to factors like the rising requirement for personalized medicine, increasing biobanks, investments in research and development, heightened healthcare spending, the escalating awareness of early disease diagnosis, the development of digital pathology, an increased need for biomarker discovery, the expanding biopharmaceutical industry, and a growing demand for point of care testing. Key trends for the forecasted period would include progress in automation technology, the incorporation of AI and machine learning, digital pathology integration, the acceptance of 3D tissue sectioning methods, the development of advanced throughput solutions, the broadening of research applications, innovation in cutting methods, improvement in imaging modes, and the use of cryosectioning techniques.

    Download a free sample to assess the report’s scope and structure:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=16555&type=smp

    What External and Internal Drivers Are Contributing to the Growth of theTissue Sectioning Market?

    The growth of the tissue sectioning market is predicted to be fueled by the increasing number of surgical processes. These procedures entail the use of medical tools for the detection, treatment, or repair of the body. The upturn in surgical processes is attributed to medical technological advancements, demographic transitions, and changes in healthcare methodologies. Tissue sectioning supplements surgical procedures by delivering exact, thin tissue sections for histological examination, fostering accurate diagnosis, treatment preparation, and transplants. For example, as reported by the Australian Institute of Health and Welfare (AIHW), a government agency in Australia for public health and welfare, there was an increase of 18% in the number of patients admitted for surgery from public hospital elective surgery waiting lists, totaling 735,500 in 2022-23, compared to 2021-22. Consequently, the escalating surgical procedures contribute to the expansion of the tissue sectioning market.

    What Segment Types Define the Tissue Sectioning Market Structure?

    The tissue sectioningmarket covered in this report is segmented –

    1) By Product: Accessories And Consumables; Instruments; Services

    2) By Technology: Automatic; Manual; Semi-Automatic

    3) By Application: Diagnosis; Research

    4) By End-User: Clinics; Diagnostic Laboratories; Hospitals; Research Centers

    Subsegments:

    1) By Accessories And Consumables: Microtome Blades; Staining Reagents; Tissue Embedding Media; Mounting Media; Disposable Consumables (Slides, Coverslips)

    2) By Instruments: Microtomes (Manual, Semi-Automated, Fully Automated); Cryostats; Tissue Processors; Tissue Embedding Stations; Sectioning Systems

    3) By Services: Maintenance And Repair Services; Calibration Services; Installation Services; Training Services

    Request customized data on this market:

    https://www.thebusinessresearchcompany.com/customise?id=16555&type=smp

    Which Geographic Areas Hold the Strongest Growth Potential in the Tissue Sectioning Market?

    North America was the largest region in the tissue sectioning market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the tissue sectioning market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    What Long-Term Trends Are Transforming the Competitive Landscape of the Tissue Sectioning Market?

    Pioneering corporations in the tissue sectioning market are spearheading the advent of superior technologies like the next-generation spatial gene expression technology to augment tissue analysis and diagnostic methods. This cutting-edge technology facilitates comprehensive gene activity mapping within tissue sections, delivering crucial understanding of the spatial arrangement of gene expression and tissue architecture. For example, 10x Genomics, a biotechnology firm based in the United States, unveiled the Visium HD in March 2024. This technology, a breakthrough in spatial gene expression, provides an exact gene expression mapping in highly detailed anatomical structures. It’s developed to yield high-resolution spatial gene expression data at a single-cell scale resolution from formalin-fixed, paraffin-embedded (FFPE) tissue sections. Consequently, this technology permits a thorough characterization of FFPE tissue sections by gauging spatial gene expression of the entire transcriptome at single-cell resolution.

    View the full report here:

    https://www.thebusinessresearchcompany.com/report/tissue-sectioning-global-market-report

    What Is the Definition of the Tissue Sectioning Market?

    Tissue sectioning is a crucial technique in histology and pathology to prepare thin tissue slices for microscopic examination. This process is essential for studying the microscopic structure of tissues and understanding the pathological changes associated with diseases.

    Purchase the full report and get a swift delivery:

    https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16555

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Europe +44 7882 955267

    Asia & Others +44 7882 955267 & +91 8897263534

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model